OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Publication Date
Release Date
2022
(7)
2024
(5)
2023
(4)
2025
(2)
2020
(2)
2019
(2)
2016
(2)
2026
(1)
2021
(1)
2017
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine.
Not available
S-EPMC4818045
|
biostudies-literature
Cite
Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events.
Not available
S-EPMC7737372
|
biostudies-literature
Cite
A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies.
Not available
S-EPMC9412414
|
biostudies-literature
Cite
Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies.
Not available
S-EPMC7699381
|
biostudies-literature
Cite
Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis.
Not available
S-EPMC6763640
|
biostudies-literature
Cite
New Pyrazolo-Benzimidazole Mannich Bases with Antimicrobial and Antibiofilm Activities.
Not available
S-EPMC9405415
|
biostudies-literature
Cite
Synthesis, Spectroscopic Characterization, Structural Analysis, and Evaluation of Anti-Tumor, Antimicrobial, and Antibiofilm Activities of Halogenoaminopyrazoles Derivatives
Not available
S-EPMC11672400
|
biostudies-literature
Cite
Design, Synthesis, Spectral, Structural Analysis, and Biological Evaluation of Novel Pyrazole Derivatives as Anti-Tumor, Antimicrobial, and Anti-Biofilm Agents
Not available
S-EPMC12937307
|
biostudies-literature
Cite
CDK8/19 inhibition triggers a switch from mitosis to endomitosis in cord blood megakaryocytes.
Not available
S-EPMC11637730
|
biostudies-literature
Cite
Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer.
Not available
S-EPMC4869764
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets